![]() Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | ||
Founding Date | Founding Date 2018 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 188 | Employees 16135% increase |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 452 m |
Financial | ||
Revenue (est.) | Revenue (est.) $130k (FY, 2023) | Revenue (est.) $34.2m (FY, 2023) |
Net income | Net income ($234.6m) (FY, 2023) | Net income ($98.4m) (FY, 2023) |
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company